Skip to content
My WebMD Sign In, Sign Up

Breast Cancer Health Center

Font Size

Breast Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Overview

Note: Separate PDQ summaries on Breast Cancer Prevention, Breast Cancer Treatment, Male Breast Cancer Treatment, and Breast Cancer Treatment and Pregnancy are also available.

This summary covers the topic of breast cancer screening and includes information about breast cancer incidence and mortality, risk factors for breast cancer, the process of breast cancer diagnosis, and the benefits and harms of various breast cancer screening modalities. This summary also includes information about screening among special populations.

Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years. Clinical breast examination and breast self-exam have also been evaluated but are of uncertain benefit. Technologies such as ultrasound, magnetic resonance imaging, tomosynthesis, and molecular breast imaging are being evaluated, usually as adjuncts to mammography.

Screening With Mammography

Benefits

Based on solid evidence, screening mammography may lead to the following benefit:

  • Decrease in breast cancer mortality
    Magnitude of Effect: In the randomized controlled trials (RCTs), for women aged 40 to 74 years, screening with mammography has been associated with a 15% to 20% relative reduction in mortality due to breast cancer.[1] Absolute mortality benefit for women screened annually for 10 years is approximately 1% overall, ranging from 4 per 10,000 for women who start screening at age 40 years to 50 per 10,000 women who start at age 50 years.[2]
    Study Design: RCTs, population-based evidence.
    Internal Validity: Variable, but meta-analysis of RCTs good.
    Consistency: Fair.
    External Validity: Good.

Harms

Based on solid evidence, screening mammography may lead to the following harms:

  • Overdiagnosis and Resulting Treatment of Insignificant Cancers: Diagnosis of cancers that would otherwise never have caused symptoms or death in a woman's lifetime can expose a woman to the immediate risks of therapy (surgical deformity or toxicities from radiation therapy, hormone therapy or chemotherapy), late sequelae (lymphedema), and late effects of therapeutic radiation (new cancers, scarring, or cardiac toxicity).
    Magnitude of Effect: Varies with patient age, tumor type, and grade, and is greater with the first screen than subsequent screening examinations.[3,4] Of all breast cancers detected by screening mammograms, up to 54% are estimated to be results of overdiagnosis.[5]
    Study Design: Descriptive population-based comparisons, autopsy series, and series of mammary reduction specimens.
  • False-Positives with Additional Testing and Anxiety.
    Magnitude of Effect: On average, 10% of women will be recalled from each screening examination for further testing, and only 5 of the 100 women recalled will have cancer.[6] Approximately 50% of women screened annually for 10 years in the United States will experience a false-positive, of whom 7% to 17% will have biopsies.[7,8] Additional testing is less likely when prior mammograms are available for comparison.
    Study Design: Descriptive population-based.
  • False-Negatives with False Sense of Security and Potential Delay in Cancer Diagnosis.
    Magnitude of Effect: 6% to 46% of women with invasive cancer will have negative mammograms, especially if they are young, have dense breasts,[9,10] or have mucinous, lobular, or rapidly growing cancers.[11]
    Study design: Descriptive population-based.
  • Radiation-Induced Breast Cancer: Radiation-induced mutations can cause breast cancer, especially if exposure occurs before age 30 years and to high levels such as from mantle radiation therapy for Hodgkin disease. One Sv is equivalent to 200 mammograms. Latency is at least 8 years, and the increased risk is lifelong.[12,13]
    Magnitude of Effect: Between 9.9 and 32 breast cancer cases per 10,000 women exposed to a cumulative dose of 1 Sv, the risk being higher in younger women. Cumulative average environmental radiation can be estimated to be about 1 Sv in 30 years. This 1 Sv is acquired in 30 years cumulative average environmental radiation or in about 200 mammograms. By contrast, one computed tomography scan is associated with exposure to 4 Sv of radiation.[12,13]
    Study design: Descriptive population-based.
1|2

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW